Rapid DNA tooling Leverage Switchback Systems' scalable DNA synthesis platform to target biotech labs and contract research organizations seeking faster, cheaper, and less wasteful synthetic biology workflows.

Early stage growth With a recent funding round and revenue in the low-to-mid range, pursue partnerships with venture-backed startups and academia looking to scale synthetic biology capabilities quickly.

Cost and waste reduction Position offerings around significant time, cost, and waste reductions to attract customers in pharma, agriculture, and plastics where efficiency drives ROI and regulatory timelines improve.

Global yet nimble Target mid-market and regional teams in large industrial players who value agility; emphasize scalable, cloud-enabled tools that integrate with existing workflows.

Tech and training Propose enablement packages including hands-on training, modular deployment, and support for cloud-based infrastructure to accelerate adoption among researchers and LIMS integrations.